{"id":"W4393059054","doi":"10.1080/17474124.2024.2326838","title":"Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials","year":2024,"lang":"en","type":"article","venue":"Expert Review of Gastroenterology & Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Pfizer Japan; Eli Lilly Japan; Allergan; Genentech; Mitsubishi Tanabe Pharma Corporation; Celltrion; Boston Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Celltrion Healthcare; Pfizer; Kyorin Pharmaceutical; EA Pharma Co., Ltd.; Gilead Sciences; Amgen","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Clinical trial; Colectomy; Colorectal cancer; Disease; Internal medicine; Clinical endpoint; Microscopic colitis; Colonoscopy; Gastroenterology; Surrogate endpoint; Pathology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08015853,0.0008950726,0.007240797,0.001821889,0.0005638365,0.005466046,0.002355361,0.004064167,0.005925876],"category_scores_gemma":[0.1471723,0.0005748878,0.005103197,0.00321434,0.002476345,0.004160029,0.001592864,0.007176141,0.001188971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002230312,"about_ca_system_score_gemma":0.003346336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009422752,"about_ca_topic_score_gemma":0.001607342,"domain_scores_codex":[0.9499034,0.03346914,0.006495469,0.002760577,0.00687711,0.0004942508],"domain_scores_gemma":[0.6942877,0.2622315,0.0226124,0.004521595,0.01474912,0.001597652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008762471,0.0001593635,0.004043181,0.1334281,0.009203547,0.00007596482,0.0002064032,0.0007100838,0.0008100832,0.01577576,0.02660378,0.8002211],"study_design_scores_gemma":[0.007161407,0.005925501,0.02368111,0.413968,0.02726293,0.0008228329,0.0004724848,0.002081397,0.001762259,0.04863006,0.4679747,0.000257413],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000678563,0.9883586,0.001304522,0.006451769,0.001510832,0.0001464744,0.0001533786,0.00001688341,0.00137892],"genre_scores_gemma":[0.03156817,0.9350914,0.008575223,0.0169147,0.005670825,0.0008177207,0.000474646,0.00005920776,0.0008280685],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08015853,"threshold_uncertainty_score":0.4239239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08193311081722345,"score_gpt":0.4517310636249114,"score_spread":0.369797952807688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}